hepcortespenlisimut-l
Trade name: Hepko V5
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02256514)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hepcortespenlisimut-l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02232490 | Phase 3 | Jan 1, 2015 | Immunitor LLC |
| NCT02256514 | Phase 2 | Sep 1, 2014 | Immunitor LLC |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immunitor LLC | For profit | 2 | 2 | 2 | 2014 |
1 organizations
Page 1 / 1